NCT01051817 - POC-MD MRI-based Trial in Relapsing-remitting Multiple Scler | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions

Relapsing-remitting Multiple SclerosisRRMS

Interventions

DRUG

AIN457

infusion 10 mg/Kg

DRUG

Placebo

infusion

Trial Locations (16)

Novartis Investigative Site, Vinnitsya

Novartis Investigative Site, Kharkiv

Novartis Investigative Site, Odesa

Novartis Investigative Site, Moscow

Novartis Investigative Site, Smolensk

Novartis Investigative Site, Kazan'

Novartis Investigative Site, Nizhny Novgorod

Novartis Investigative Site, Hradec Králové

Novartis Investigative Site, Ostrava

Novartis Investigative Site, Ostrava-Moravska Ostrava

Novartis Investigative Site, Prague

Novartis Investigative Site, Kharkiv

Novartis Investigative Site, Kiev

Novartis Investigative Site, Prague

Novartis Investigative Site, Teplice

Novartis Investigative Site, Kiev